VentriPoint Historical Balance Sheet
VPT Stock | CAD 0.14 0.01 7.69% |
Trend analysis of VentriPoint Diagnostics balance sheet accounts such as Total Assets of 2 M, Total Current Liabilities of 2.1 M, Total Stockholder Equity of 199.2 K or Accounts Payable of 792.1 K provides information on VentriPoint Diagnostics' total assets, liabilities, and equity, which is the actual value of VentriPoint Diagnostics to its prevalent stockholders. By breaking down trends over time using VentriPoint Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining VentriPoint Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether VentriPoint Diagnostics is a good buy for the upcoming year.
VentriPoint Diagnostics Inventory |
|
VentriPoint |
About VentriPoint Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of VentriPoint Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. VentriPoint Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of VentriPoint Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which VentriPoint currently owns. An asset can also be divided into two categories, current and non-current.
VentriPoint Diagnostics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of VentriPoint Diagnostics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in VentriPoint Diagnostics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on VentriPoint Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of VentriPoint Diagnostics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents VentriPoint Diagnostics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of VentriPoint Diagnostics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of VentriPoint Diagnostics balance sheet. This account contains VentriPoint Diagnostics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by VentriPoint Diagnostics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most accounts from VentriPoint Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, VentriPoint Diagnostics' Total Current Assets are fairly stable compared to the past year. Non Current Liabilities Total is likely to climb to about 468.6 K in 2024, despite the fact that Retained Earnings are likely to grow to (50.8 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Current Liabilities | 1.1M | 1.1M | 1.4M | 2.1M | Total Assets | 9.5M | 6.0M | 1.9M | 2.0M |
VentriPoint Diagnostics balance sheet Correlations
Click cells to compare fundamentals
VentriPoint Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VentriPoint Diagnostics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 314.3K | 801.6K | 9.5M | 6.0M | 1.9M | 2.0M | |
Total Current Liabilities | 1.9M | 1.8M | 1.1M | 1.1M | 1.4M | 2.1M | |
Total Stockholder Equity | (2.5M) | (2.3M) | 8.3M | 4.6M | 189.7K | 199.2K | |
Net Debt | 1.1M | 843.8K | (9.1M) | (4.7M) | (1.0M) | (969.0K) | |
Retained Earnings | (37.9M) | (39.9M) | (43.7M) | (48.6M) | (53.5M) | (50.8M) | |
Accounts Payable | 1.2M | 1.0M | 988.6K | 842.0K | 856.2K | 792.2K | |
Cash | 13.8K | 526.0K | 9.3M | 5.2M | 1.3M | 1.5M | |
Cash And Short Term Investments | 13.8K | 526.0K | 9.3M | 5.2M | 1.3M | 1.5M | |
Net Receivables | 67.7K | 165.3K | 197.5K | 374.2K | 285.5K | 299.8K | |
Common Stock Shares Outstanding | 63.4M | 74.5M | 136.1M | 156.0M | 156.8M | 164.7M | |
Liabilities And Stockholders Equity | 314.3K | 801.6K | 9.5M | 6.0M | 1.9M | 2.0M | |
Other Stockholder Equity | 6.0M | 6.4M | 9.8M | 10.4M | 10.9M | 7.5M | |
Total Liab | 2.8M | 3.2M | 1.2M | 1.4M | 1.7M | 2.6M | |
Total Current Assets | 176.0K | 714.5K | 9.5M | 5.7M | 1.6M | 1.9M | |
Non Current Liabilities Total | 868.0K | 1.3M | 125.4K | 367.4K | 297.0K | 468.6K | |
Property Plant And Equipment Net | 138.3K | 87.1K | 42.5K | 313.3K | 246.6K | 258.9K | |
Non Current Assets Total | 138.3K | 87.1K | 42.5K | 313.3K | 246.6K | 134.6K | |
Other Current Liab | 12.8K | 500.0 | 62.3K | 122.1K | 453.6K | 753.2K | |
Short Term Debt | 257.1K | 42.8K | 34.6K | 91.6K | 55.0K | 52.3K | |
Net Tangible Assets | (1.7M) | (1.0M) | (2.5M) | (2.3M) | (2.1M) | (2.2M) | |
Other Current Assets | 63.8K | 23.1K | 35.9K | 103.5K | 56.9K | 73.8K | |
Common Stock | 29.5M | 31.0M | 42.2M | 42.7M | 49.1M | 28.8M | |
Property Plant Equipment | 49.9K | 49.0K | 138.3K | 87.1K | 100.1K | 71.6K | |
Net Invested Capital | (1.5M) | (1.1M) | 8.5M | 4.7M | 327.8K | 311.4K | |
Net Working Capital | (1.7M) | (1.1M) | 8.4M | 4.6M | 240.1K | 228.1K | |
Capital Stock | 29.5M | 31.0M | 42.2M | 42.7M | 49.1M | 39.7M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.